Carles Codina
YOU?
Author Swipe
View article: POS0268 ESOPHAGEAL DYSMOTILITY PATTERNS ARE ASSOCIATED WITH MORE SEVERE FEATURES AND WORSE OUTCOMES IN PATIENTS WITH SYSTEMIC SCLEROSIS
POS0268 ESOPHAGEAL DYSMOTILITY PATTERNS ARE ASSOCIATED WITH MORE SEVERE FEATURES AND WORSE OUTCOMES IN PATIENTS WITH SYSTEMIC SCLEROSIS Open
View article: POS0562 Evaluation of Small bowel Involvement in Systemic Sclerosis Using Morpho-Functional Image Analysis Assisted by Artificial Intelligence
POS0562 Evaluation of Small bowel Involvement in Systemic Sclerosis Using Morpho-Functional Image Analysis Assisted by Artificial Intelligence Open
View article: ABS0570 PULMONARY VENO-OCLUSIVE DISEASE AND PREDICTIVE VALUE OF CHEST CT PVOD SIGNS IN A COHORT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION ASSOCIATED TO SYSTEMIC SCLEROSIS
ABS0570 PULMONARY VENO-OCLUSIVE DISEASE AND PREDICTIVE VALUE OF CHEST CT PVOD SIGNS IN A COHORT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION ASSOCIATED TO SYSTEMIC SCLEROSIS Open
View article: ABS0918 ANTI-U11/U12RNP AS A BIOMARKER OF POOR PROGNOSIS IN SYSTEMIC SCLEROSIS WITH INTERSTITIAL LUNG DISEASE: A SURVIVAL ANALYSIS
ABS0918 ANTI-U11/U12RNP AS A BIOMARKER OF POOR PROGNOSIS IN SYSTEMIC SCLEROSIS WITH INTERSTITIAL LUNG DISEASE: A SURVIVAL ANALYSIS Open
View article: Impact of gastrointestinal symptoms and psychological distress on quality of life in systemic sclerosis: a cross-sectional study
Impact of gastrointestinal symptoms and psychological distress on quality of life in systemic sclerosis: a cross-sectional study Open
Background Systemic sclerosis (SSc) is a chronic autoimmune disease characterised by microvascular damage and fibrosis. Mortality in patients with SSc has significantly decreased. Consequently, patients with SSc have longer life expectancy…
View article: POS1312 PREVALENCE OF GASTROINTESTINAL SYMPTOMS AND OBJECTIVE GASTROINTESTINAL DYSMOTILITY IN PATIENTS WITH SYSTEMIC SCLEROSIS
POS1312 PREVALENCE OF GASTROINTESTINAL SYMPTOMS AND OBJECTIVE GASTROINTESTINAL DYSMOTILITY IN PATIENTS WITH SYSTEMIC SCLEROSIS Open
View article: AB0832 CHRONIC INTESTINAL PSEUDO-OBSTRUCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS
AB0832 CHRONIC INTESTINAL PSEUDO-OBSTRUCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS Open
View article: POS1325 TREATMENT WITH NINTEDANIB IN SYSTEMIC SCLEROSIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE: SAFETY AND EFFECTIVENESS AFTER ONE YEAR IN A REAL-LIFE COHORT
POS1325 TREATMENT WITH NINTEDANIB IN SYSTEMIC SCLEROSIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE: SAFETY AND EFFECTIVENESS AFTER ONE YEAR IN A REAL-LIFE COHORT Open
View article: A case study of polypharmacy management in nine European countries: Implications for change management and implementation
A case study of polypharmacy management in nine European countries: Implications for change management and implementation Open
Within the studied EU countries, polypharmacy management was not widely addressed. These results highlight the importance of change management and theory-based implementation strategies, and provide examples of polypharmacy management init…
View article: Design of a relative value unit-based tool for the measurement and reimbursement of pharmacy services for clinical trials
Design of a relative value unit-based tool for the measurement and reimbursement of pharmacy services for clinical trials Open
The application of RVU methodology in investigational drug services allows a more precise quantification of services performed. After a prospective validation to confirm the applicability of this tool, it may contribute to more appropriate…
View article: A modified Delphi study to determine the level of consensus across the European Union on the structures, processes and desired outcomes of the management of polypharmacy in older people
A modified Delphi study to determine the level of consensus across the European Union on the structures, processes and desired outcomes of the management of polypharmacy in older people Open
Consensus was obtained amongst key EU strategists around many aspects of polypharmacy management in older people. Notably, no consensus was achieved in relation to statements relating to the need to alter legislation in areas of healthcare…
View article: Medication review and polypharmacy management in the hospital setting. The cases of Greece and Catalonia
Medication review and polypharmacy management in the hospital setting. The cases of Greece and Catalonia Open
Introduction: Medication review and polypharmacy management, especially in the elderly, are key components of integrated care. Although polypharmacy management is often associated with the primary care setting, hospital clinicians, who are…
View article: Polypharmacy and Integrated Care: Identifying synergies in implementation
Polypharmacy and Integrated Care: Identifying synergies in implementation Open
Introduction: Integrated care has the potential to assist health systems in achieving the triple aims of improving the experiences of individual patients, the health of the population, whilst at the same time increasing efficiencies. Integ…
View article: Polypharmacy and Adherence: Key Components of Integrated Care Findings from the SIMPATHY Project
Polypharmacy and Adherence: Key Components of Integrated Care Findings from the SIMPATHY Project Open
Context, aims and objectives: As many as half of all patients with chronic conditions are using their medicines in a way that is not fully effective, resulting in sub-optimal treatment and subsequent increases in hospitalisations and emerg…
View article: Polypharmacy and Adherence: Key Components of Integrated Care, The case of Catalonia
Polypharmacy and Adherence: Key Components of Integrated Care, The case of Catalonia Open
Introduction: Polypharmacy and medication adherence in the older population are significant public health issues throughout the European Union (EU), and are an important component of integrated care. SIMPATHY (Stimulating Innovation Manage…
View article: Polypharmacy management: an under recognized public health issue
Polypharmacy management: an under recognized public health issue Open
BackgroundMultiple chronic diseases in individuals increase the risk of inappropriate polypharmacy, an under recognised public health issue. SIMPATHY (Stimulating Innovation Management of Polypharmacy and Adherence in The Elderly) aims to …
View article: PKP-006 Comparison between the use of total/ideal/adjusted body weight for empirical vancomycin dosing in obese patients
PKP-006 Comparison between the use of total/ideal/adjusted body weight for empirical vancomycin dosing in obese patients Open
Background Pharmacokinetic studies have suggested that total body weight (TBW) could be the optimal approach to calculate the dose of intravenous vancomycin (15–20 mg/kg TBW every 8–12 h) for target achievement (Css > 15 mg/L).1…